SecProbe.io

CORRESP
1
filename1.htm

VIA
EDGAR

March
27, 2024

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, NE

Washington,
D.C., 20549

 Re: Gelteq
Limited

Registration
Statement on Form F-1, as amended

File
No. 333-267169

Ladies
and Gentlemen:

Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), R.F. Lafferty & Co., Inc.,
as the representative of the underwriters (the “Representative”), hereby join in the request of Gelteq Limited (the “Registrant”),
for the acceleration of the effective date of the Registrant’s Registration Statement on Form F-1 (File No. 333-267169) (as amended,
the “Registration Statement”), so that the Registration Statement may be declared effective at 4:00 p.m., Eastern Time, on
March 29, 2024, or as soon thereafter as practicable. The undersigned, as the Representative, confirms that it is aware of its obligations
under the Securities Act.

The
undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended,
in connection with the above-referenced issue.

    Very truly yours,

    R.F. Lafferty & Co., Inc.

    By:
    /s/
    John Heidenreich

    Name:
    John
    Heidenreich

    Title:
    Head
    of Equity Capital Markets